Bartonella bacilliformis infection

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:64692A44.0
Who is this for?
Show terms as
3FDA treatments8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bartonella bacilliformis infection, also known as Carrión's disease or Oroya fever (in its acute phase) and Verruga peruana (in its chronic phase), is a rare bacterial infection caused by the bacterium Bartonella bacilliformis. This infection is spread through the bite of infected sandflies, particularly Lutzomyia verrucarum, and is found almost exclusively in certain mountainous regions of South America, especially Peru, Ecuador, and Colombia. The disease has two distinct stages. The first stage, called Oroya fever or the acute phase, is a serious illness where the bacteria invade red blood cells and destroy them, causing severe anemia. This can be life-threatening if not treated quickly. Symptoms include high fever, chills, headache, muscle pain, and extreme fatigue. The second stage, called Verruga peruana or the chronic phase, causes distinctive reddish-purple skin growths or wart-like bumps that can appear weeks to months after the initial infection. These skin lesions are usually not life-threatening but can be uncomfortable and disfiguring. Fortunately, Bartonella bacilliformis infection responds well to antibiotic treatment. The acute phase is typically treated with antibiotics such as ciprofloxacin or chloramphenicol, while the chronic skin phase is often treated with rifampicin or azithromycin. With prompt diagnosis and proper antibiotic therapy, most people recover fully. Without treatment, the acute phase can be fatal in a significant number of cases.

Also known as:

Key symptoms:

High feverSevere anemia (low red blood cell count causing extreme tiredness and paleness)Chills and shakingHeadacheMuscle and joint painNausea and vomitingYellowing of the skin or eyes (jaundice)Enlarged lymph nodesReddish-purple wart-like skin bumps or nodules (in the chronic phase)Skin lesions that may bleed easilyExtreme fatigue and weaknessRapid heart rateDizziness or fainting

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Mar 2024A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Janssen Research & Development, LLC — PHASE3

TrialRECRUITING
Jul 2022A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Janssen Research & Development, LLC — PHASE2

TrialACTIVE NOT RECRUITING
Jun 2020A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Eli Lilly and Company — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

3 available

Epclusa

sofosbuvir and velpatasvir· Gilead Sciences, Inc.■ Boxed Warning

EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection with compensated cirrhosis

MAVYRET

glecaprevir and pibrentasvir· AbbVie, Inc.■ Boxed Warning
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with c

MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).

Remicade

infliximab· Janssen Biotech, Inc.■ Boxed Warning

reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy

No actively recruiting trials found for Bartonella bacilliformis infection at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bartonella bacilliformis infection community →

No specialists are currently listed for Bartonella bacilliformis infection.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
⚗️ Trial Site

Children's Hospital of Philadelphia

📍 Philadelphia, Pennsylvania

👤 Study Director

👤 Richard Neibeger, MD

⚗️ Trial Site

Cedars Sinai Medical Center

📍 Los Angeles, California

👤 Janssen Research & Development, LLC Clinical Trial

⚗️ Trial Site

Columbia University Medical Center

📍 New York, New York

👤 Janssen Research & Development, LLC Clinical Trial

👤 Anthony A. Amato, MD

⚗️ Trial Site

Emory University

📍 Atlanta, Georgia

⚗️ Trial Site

Connecticut Children's Medical Center

📍 Hartford, Connecticut

⚗️ Trial Site

University of Colorado

📍 Aurora, Colorado

⚗️ Trial Site

Riley Hospital for Children

📍 Indianapolis, Indiana

⚗️ Trial Site

University of California San Francisco

📍 San Francisco, California

Financial Resources

2 resources
Epclusa(sofosbuvir and velpatasvir)Gilead Sciences, Inc.
Remicade(infliximab)Janssen Biotech, Inc.

Travel Grants

No travel grants are currently matched to Bartonella bacilliformis infection.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bartonella bacilliformis infectionForum →

No community posts yet. Be the first to share your experience with Bartonella bacilliformis infection.

Start the conversation →

Latest news about Bartonella bacilliformis infection

Disease timeline:

New trial: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Phase PHASE3 trial recruiting. Mirikizumab

New trial: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Seve

Phase PHASE2 trial recruiting. Guselkumab

New trial: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Phase PHASE3 trial recruiting. Guselkumab

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which phase of Bartonella bacilliformis infection do I have, and what does that mean for my treatment?,What antibiotic will I be prescribed, and how long do I need to take it?,Do I need a blood transfusion because of anemia, and how will you monitor my blood counts?,What warning signs should prompt me to go to the emergency room?,How will we know the treatment has worked, and what follow-up tests are needed?,Am I at risk of developing the chronic skin phase (Verruga peruana) after the acute illness?,How can I prevent reinfection if I live in or plan to return to an endemic area?

Common questions about Bartonella bacilliformis infection

What is Bartonella bacilliformis infection?

Bartonella bacilliformis infection, also known as Carrión's disease or Oroya fever (in its acute phase) and Verruga peruana (in its chronic phase), is a rare bacterial infection caused by the bacterium Bartonella bacilliformis. This infection is spread through the bite of infected sandflies, particularly Lutzomyia verrucarum, and is found almost exclusively in certain mountainous regions of South America, especially Peru, Ecuador, and Colombia. The disease has two distinct stages. The first stage, called Oroya fever or the acute phase, is a serious illness where the bacteria invade red blood

How is Bartonella bacilliformis infection inherited?

Bartonella bacilliformis infection follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

What treatment and support options exist for Bartonella bacilliformis infection?

2 patient support programs are currently tracked on UniteRare for Bartonella bacilliformis infection. See the treatments and support programs sections for copay assistance, eligibility, and contact details.